SecBot SecBot

TFX

TELEFLEX INC
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000096943 Healthcare & Medical Devices
$157.10 +2.00 (+1.29%)
Nov 16 4:00 PM ET · prev $155.10
Market cap
$6.1B
Mid cap
Consensus
Buy
50% Buy or better · 18 analysts
Median target
$169.00
+8% · range $158.00–178.00
1 year
+51.3%
from $103.86 · Nov 17
30 days
+21.1%
from $129.68
52-week range
$100.34–157.10
at the high
Avg volume 20D
822.5K
shares / day
Short interest
4.07M
≈10.3% of shares · −3.6%
Days to cover
5.9
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 2 exits
Filing reports
11
analyzed by SecBot
SecBot read BULLISH 2 reports · 90 days
Balance 0 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/2

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q2 2026: 29 added (0 new), 18 trimmed or exited.

  • AnalystsBULLISH

    9 of 18 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −3.6% to 4.07M shares. 5.9 days to cover, ≈10.3% of shares.

  • TrendUPTREND

    17% above its 50-day average. New closing high $157.10 on Nov 16.

Who's buying

13F· Q2 2026
0
new positions
2
exits
FundMoveSharesValue
MILLENNIUM MANAGEMENT LLCDOUBLED1,442,103$182.8M
GOLDMAN SACHS GROUP INCDOUBLED905,779$114.8M
Holocene Advisors, LPDOUBLED886,281$112.3M
NORGES BANKADD684,425$86.8M
JPMORGAN CHASE & CODOUBLED394,502$50.6M
UBS Group AGADD391,891$49.7M
BNP PARIBAS FINANCIAL MARKETSDOUBLED305,197$38.7M
Quantinno Capital Management LPDOUBLED158,306$20.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

18 analysts
Buy 50% rate it Buy or better
Strong Buy2Buy7Hold9Sell0Strong Sell0
12-month targets · 11 analysts

Price is below the lowest target. Median implies +8%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 9, 2026Truist Securities
MAINTAIN
MAINTAINHold
Nov 6, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Nov 6, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Oct 14, 2026Truist Securities
MAINTAIN
MAINTAINHold
Sep 28, 2026B of A Securities
UPGRADE
UPGRADEBuy
Aug 25, 2026Needham
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Sep 8, 2026
Salmon Sean
Director
Sep 8, 2026
AWARD4,444 sh
Sep 8, 2026
Salmon Sean
Director
Sep 8, 2026
AWARD674 sh
Jun 8, 2026
Weidman Jason R.
President and CEO
Jun 8, 2026
AWARD53,983 sh
Jun 8, 2026
Weidman Jason R.
President and CEO
Jun 8, 2026
AWARD26,071 sh
Jun 8, 2026
RANDLE STUART A
Director
Jun 8, 2026
AWARD995 sh
Jun 8, 2026
RANDLE STUART A
Director
Jun 8, 2026
AWARD2,192 sh
Jun 8, 2026
RANDLE STUART A
Director
Jun 8, 2026
AWARD4,663 sh
Jun 7, 2026
RANDLE STUART A
Director
Jun 7, 2026
TAX W/H$526.4K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

15 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
4,066,318
shares short
-3.6%
vs prior settlement
5.9
days to cover
≈10.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 5, 2026 SEC
Teleflex Q3 2026 revenue of $567.8M was essentially flat YoY (+0.2% reported, +3.0% pro forma adjusted constant…
8-K · Impact 6/10
Nov 5, 2026 Earnings result
TFX Q3 2026 Earnings: EPS $2.63 (+36.8% vs est)
Sep 8, 2026 Insider
Salmon Sean was granted 4,444 shares
Director
Sep 8, 2026 Insider
Salmon Sean was granted 674 shares
Director
Aug 6, 2026 SEC
Teleflex reported Q2 2026 adjusted EPS of $1.76, a 37.4% beat vs the $1.28 consensus, driven by strong Vascular and…
8-K · Impact 6/10
Jul 2, 2026 Event
Berall v. Teleflex Medical Inc.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 25-1124
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC · DOUBLED
1,442,103 shares ($182.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

11 filings · 2 bullish · 0 bearish · 4 mixed · 5 neutral
All TFX filing & press-release reports (11)